|
2024
|
Invention
|
Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereof. The present d... |
|
|
Invention
|
Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropi... |
|
2022
|
Invention
|
3-(substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositi... |
|
|
Invention
|
Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disor... |
|
|
Invention
|
Combination therapy using enantiopure, oxy-substituted, deuterium-enriched 5-(benzyl)-5-deutero-t... |
|
2019
|
Invention
|
H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of usin... |
|
2018
|
Invention
|
Deuterium-enriched isoindolinonyl-azepanediones and related compounds and methods of treating med... |
|
|
Invention
|
2',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compounds.
The present application describes 2-... |
|
2017
|
Invention
|
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4h)-yl-piperidinon... |
|
2016
|
Invention
|
Methods of treating bacterial infections and fungal infections using enantiopure deuterium-enrich... |
|
|
Invention
|
5-deutero-thiazolidine-2,4-dione compounds and methods of treating medical disorders using same. ... |
|
|
Invention
|
5-deutero-thiazolidinyldione compounds and methods of treating medical disorders using same. The ... |
|
2015
|
Invention
|
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enri... |
|
2014
|
Invention
|
3-(substituted-4-oxo-quinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives. The inventi... |
|
|
Invention
|
Deuterium-enriched 2,4-thiazolidinediones and methods of treatment. The invention provides 5 -deu... |
|
|
Invention
|
Deuterium-enriched prasugrel.
The present application describes deuterium-enriched prasugrel, ph... |
|
|
Invention
|
5-deutero-2,4-thiazolidinedione and 5-deutero-2,4-oxazolidinedione derivatives and compositions c... |
|
|
Invention
|
3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives. The invent... |
|
2013
|
Invention
|
Deuterium-enriched bupropion. The present application describes deuterium-enriched bupropion, pha... |
|
2012
|
Invention
|
Deuterium-enriched donepezil. The present application describes deuterium-enriched donepezil, pha... |
|
|
Invention
|
2',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compounds. The present application describes 2-(... |
|
|
Invention
|
2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds. The present application describes 2-(2′,... |
|
2008
|
Invention
|
Deuterium-enriched ondansetron. The present application describes deuterium-enriched ondansetron,... |
|
|
Invention
|
Deuterium-enriched prasugrel. The present application describes deuterium-enriched prasugrel, pha... |
|
|
Invention
|
Deuterium-enriched bupropion.
The present application describes deuterium-enriched bupropion, ph... |
